Extreme Omega 2400 mg Lemon Natural Flavor

Extreme Omega 2400 mg Lemon Natural Flavor

Natrol4.8 (795 ratings)
Format:Softgel Quantity: 60 Softgel(s) · 30 servings
Goals
$11.99 $0.39 per serving

Product analysis

51 out of 100

Extreme Omega 2400 mg Lemon Natural Flavor supplies EPA and DHA at favorable value, with the clearest role in supporting triglyceride metabolism. Their individual amounts make the active omega-3 contribution easier to compare than total oil weight alone.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

The specific EPA and DHA forms are not disclosed. That limits a clear comparison of absorption quality, without establishing that the oil itself is poor quality.

Ingredient Transparency40

EPA and DHA amounts are stated separately, helping you compare the active omega-3 content. Several other amounts, forms and component details are missing, so the full fat profile is less clear.

Value For Money72

EPA and DHA offer favorable value at the whole-product cost. Value for the other fat components cannot be judged confidently.

Customer Satisfaction82

Customer feedback is very positive across several hundred ratings. The review base supports the satisfaction picture without proving cardiovascular benefits.

Product Focus69

EPA and DHA give the formula a clear omega-3 purpose, centered on triglyceride metabolism. Changes in blood markers do not establish noticeable symptom relief or prevention of cardiovascular events.

Format
Softgel
Container
60 Softgel(s)
Per serving
$0.39
Customer rating
4.8 · 795 ratings
Report analysis

Goals

Impact
Highest effect
B Ingredient FitC- PathwaysA+ EvidenceA+ Formulation Logic
EPA (Eicosapentaenoic Acid) · 646 mg

EPA and DHA have a connection to triglyceride and selected vascular measures. This product declares their active amounts separately, rather than relying on fish-oil mass. Routine supplementation has not demonstrated a general reduction in major cardiovascular events in the supplied primary-prevention evidence. Results from prescription purified EPA in selected high-risk patients do not transfer to this supplement.

How this product is rated for Heart Health

Ingredient fit76

EPA and DHA provide the relevant ingredient contributions. The declared amounts contribute according to their separate saved references.
Goal fit
EPA and DHA are relevant to this goal; the formula's other actives and wider uses affect how focused it is.
Dose adequacy
The relevant ingredients contribute differently according to their declared amounts and preparation-specific references.

Pathways59

EPA and DHA provide the strongest saved contribution through triglyceride metabolism. Only triglyceride metabolism meets the saved coverage threshold.
Depth
EPA and DHA provide the strongest saved contribution through triglyceride metabolism.
Breadth
Only triglyceride metabolism meets the saved coverage threshold.

Evidence100

EPA provides the strongest saved evidence contribution, with triglyceride support distinct from general cardiovascular prevention.
Evidence strength
EPA provides the strongest saved evidence contribution, with triglyceride support distinct from general cardiovascular prevention.
Studied preparation
The ingredients with qualifying amounts meet the saved preparation criteria; this does not establish finished-product efficacy or form superiority.

Formulation logic100

The contributing ingredients meet the saved minimum amount and partner conditions. No configured conflict was identified.
Partner coverage
The contributing ingredients work independently or have their required partners in the supplied findings.
Conflicts
No configured ingredient conflict was identified in the supplied facts.
Effective doses
All ingredients counted for amount contributions meet the minimum criterion, which does not guarantee clinical benefit.
Study evidence
Cardiovascular Support
Impact
Highest effect
B+ Ingredient FitC PathwaysB+ EvidenceA+ Formulation Logic
Fish Oil · 2400 mgVitamin E · 20.1 mg

The declared EPA and DHA connect this product mainly to triglyceride metabolism. Trials support triglyceride lowering at specific daily exposures and preparations, but separately declared fatty acids cannot automatically reproduce a combined-product trial. The supplied findings do not establish prevention of major cardiovascular events, and a label serving does not specify the duration or frequency used in trials.

How this product is rated for Cardiovascular Support

Ingredient fit85

The relevant ingredients give the formula a focused cardiovascular connection, although this does not prove an outcome. The counted amounts meet the saved exposure levels unevenly; smaller or unresolved amounts limit the comparison.
Goal fit
The relevant ingredients give the formula a focused cardiovascular connection, although this does not prove an outcome.
Dose adequacy
The counted amounts meet the saved exposure levels unevenly; smaller or unresolved amounts limit the comparison.

Pathways60

The strongest saved connection is triglyceride metabolism, without establishing a corresponding clinical benefit.
Depth
The strongest saved connection is triglyceride metabolism, without establishing a corresponding clinical benefit.
Breadth
The saved findings cover triglyceride metabolism; this describes selected mechanisms rather than prevention of cardiovascular events.

Evidence83

EPA declared active leads the saved evidence comparison, with the population and outcome limits described for that ingredient.
Evidence strength
EPA declared active leads the saved evidence comparison, with the population and outcome limits described for that ingredient.
Studied preparation
The counted preparations meet the saved comparison; that does not make all forms or populations equivalent to those in trials.

Formulation logic100

No required partner or configured conflict reduced the supplied formulation findings; the amount comparison remains specific to one declared serving.
Partner coverage
No required partner was missing from the counted contributions; this does not establish an additional combination benefit.
Conflicts
No configured ingredient conflict was found in the supplied findings.
Effective doses
All counted ingredients reach the saved minimum contribution level, which is not a proven cardiovascular-effective dose.
Study evidence
Fish Oil Supportive 185 studies
Vitamin E Mixed 79 studies
Inflammation
Impact
Moderate effect
C Ingredient FitF PathwaysC+ EvidenceA+ Formulation Logic
Fish Oil · 2400 mgVitamin E · 20.1 mg

EPA and DHA may lower some markers of inflammation in the blood. These marine omega-3 fats offer a more direct connection to inflammation than fish-oil weight alone, because their individual amounts are declared here. A change in a blood marker does not tell you whether you will feel better or get a broad clinical benefit.

How this product is rated for Inflammation

Ingredient fit65

EPA and DHA may lower some markers of inflammation in the blood.
Goal fit
EPA and DHA may lower some markers of inflammation in the blood.
Dose adequacy
DHA (docosahexaenoic acid): 430 mg per serving. An amount alone does not predict an increase in inflammatory symptom relief.

Pathways17

EPA and DHA may lower some markers of inflammation in the blood.
Depth
EPA and DHA may lower some markers of inflammation in the blood.
Breadth
Changes in inflammatory blood markers do not necessarily mean symptom relief or a broad health benefit.

Evidence70

EPA and DHA may lower some markers of inflammation in the blood.
Evidence strength
EPA and DHA may lower some markers of inflammation in the blood.
Studied preparation
The preparation matters: different forms and extracts cannot automatically share the same anti-inflammatory effects.

Formulation logic100

No particular ingredient conflict or missing required partner is identified.
Partner coverage
No missing required ingredient partner is identified.
Conflicts
No particular ingredient conflict is identified.
Effective doses
DHA (docosahexaenoic acid): 430 mg per serving. This is a label-serving amount, not an inferred daily intake.
Study evidence
Fish Oil Supportive 68 studies
Vitamin E Supportive 20 studies
Mental Focus
Impact
Moderate effect
C Ingredient FitD+ PathwaysC- EvidenceA+ Formulation Logic

The serving supplies 430 mg DHA and 646 mg EPA. These omega-3s relate mainly to longer-term brain support; the supplied evidence does not support expecting an immediate improvement in concentration, and DHA findings depend on intake and duration.

How this product is rated for Mental Focus

Ingredient fit62

Several ingredients relate to the goal, alongside ingredients serving other health purposes. The saved dose assessment finds partial support from the declared amounts.
Goal fit
Several ingredients relate to the goal, alongside ingredients serving other health purposes.
Dose adequacy
The saved dose assessment finds partial support from the declared amounts.

Pathways53

The strongest saved finding concerns processes associated with brain-cell maintenance and protection. One of the three target mechanisms reaches the saved coverage threshold, so coverage remains concentrated in one area.
Depth
The strongest saved finding concerns processes associated with brain-cell maintenance and protection.
Breadth
One of the three target mechanisms reaches the saved coverage threshold, so coverage remains concentrated in one area.

Evidence56

EPA provides the strongest saved evidence rating here, with a rationale centered on longer-term support rather than immediate focus. The saved assessment recognizes EPA preparation support, while DHA is not matched to a studied preparation.
Evidence strength
EPA provides the strongest saved evidence rating here, with a rationale centered on longer-term support rather than immediate focus.
Studied preparation
The saved assessment recognizes EPA preparation support, while DHA is not matched to a studied preparation.

Formulation logic100

The saved findings identify no missing required partner for the included ingredients. No configured ingredient conflict was found in the saved assessment. All ingredients included in this finding reach the saved minimum dose threshold.
Partner coverage
The saved findings identify no missing required partner for the included ingredients.
Conflicts
No configured ingredient conflict was found in the saved assessment.
Effective doses
All ingredients included in this finding reach the saved minimum dose threshold.
Study evidence

Ingredients

IngredientAmount per servingScore
Calories
30 Calorie(s)
Total Fat
3 Gram(s)
Saturated Fat
0 Gram(s)
Trans Fat
0 Gram(s)
Polyunsaturated Fat
2 Gram(s)
Monounsaturated Fat
0 Gram(s)
Cholesterol
20 mg
Vitamin E (D-Alpha-Tocopherol)
20.1 mg
Omega-3 Fish Oil
2400 mg 69
Eicosapentaenoic Acid
646 mg 69
Docosahexaenoic Acid
430 mg 62
Adults 18–50 Dairy Free
Report overview
D+ Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyB+ Value
Each serving provides 646 mg EPA and 430 mg DHA. The whole-product serving costs about $0.40.
How this ingredient is rated

Active Ingredient Quality & Bioavailability50

The molecular form of EPA is not identified in the saved information. The 646 mg EPA is about 26.9% of the 2400 mg fish oil per serving.
Molecular Form and Bioavailability
The molecular form of EPA is not identified in the saved information.
EPA Concentration Density
The 646 mg EPA is about 26.9% of the 2400 mg fish oil per serving.
Oxidation Protection
Tocopherol is recorded as an antioxidant; actual oxidation protection was not measured by the evaluation.

Dose, Safety & Label Transparency82

Each serving provides 646 mg EPA and 430 mg DHA. A purification claim is recorded.
Absolute EPA Dose per Serving
Each serving supplies 646 mg EPA.
EPA-Centric Ratio
Each serving has 646 mg EPA and 430 mg DHA, so EPA is the larger amount.
Purity and Contaminant Testing
A purification claim is recorded; a qualifying third-party contaminant-testing or certification claim is not established in the saved information.

Value80

Based on the whole-product serving price, the cost is about $0.62 per gram of EPA.
Price per Gram of EPA
Based on the whole-product serving price, the cost is about $0.62 per gram of EPA.
Fish Oil · 2400 mg OverallScore69
D- Active Ingredient Quality & BioavailabilityB Dose, Safety & Label TransparencyA+ Value
A serving provides 1076 mg of EPA and DHA combined in 2400 mg of fish oil, making up about 45% of the oil. The whole-product serving price works out to about $0.37 per gram of EPA and DHA.
How this ingredient is rated

Active Ingredient Quality & Bioavailability44

The molecular form is not established, and a specific purification method is recorded without its name. Independent testing is not established in the saved facts.
Omega-3 Molecular Form
The molecular form is not established by the saved facts; a fish oil or concentrate name alone does not identify it.
Purification & Filtration Method
A specific purification method is recorded in the evaluation, but its name is not given in the saved facts.
Third-Party Purity & Potency Verification
The saved facts do not establish an independent testing claim.
Source & Sustainability
Fish oil is recorded, but the specific fish and a sustainability certification are not identified in the saved facts.

Dose, Safety & Label Transparency79

Each serving supplies 1076 mg of EPA and DHA combined, about 45% of the 2400 mg fish oil. A qualifying antioxidant is recorded.
Total Active Omega-3 Dose (EPA + DHA)
Each serving supplies 646 mg EPA and 430 mg DHA, for 1076 mg combined.
Omega-3 Potency & Concentration
EPA and DHA together make up about 45% of the 2400 mg of fish oil per serving.
EPA & DHA Individual Disclosure
EPA and DHA are listed separately at 646 mg and 430 mg per serving, respectively.
Oxidation Protection (Stabilizers)
A qualifying antioxidant is recorded in the saved facts, although its identity is not specified there.

Value100

The whole-product serving price corresponds to about $0.37 per gram of EPA and DHA.
Cost Per Gram of Active EPA + DHA
The whole-product serving price corresponds to about $0.37 per gram of EPA and DHA.
DHA · 430 mg OverallScore62
D- Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyB+ Value
A serving provides 430 mg of fish-oil DHA. The whole-product cost works out to about $0.93 per gram of DHA.
How this ingredient is rated

Active Ingredient Quality & Bioavailability42

The DHA chemical form is not established in the saved facts. The total omega-3 concentration in the oil cannot be established from the saved facts.
DHA Chemical Form & Bioavailability
The saved facts do not establish the DHA chemical form; the source alone cannot identify it.
Oxidation Protection & Stability
A protective antioxidant inclusion is recorded; this does not measure oxidation or freshness.
Oil Concentration & Purity
The saved facts do not establish a comparable total omega-3 or combined EPA and DHA amount alongside the oil amount, so concentration is unknown.

Dose, Safety & Label Transparency73

A serving provides 430 mg of DHA. The saved facts do not establish measured contaminant results.
DHA Absolute Dosage
A serving provides 430 mg of DHA, a middle amount in the evaluation’s comparison.
Purity & Heavy Metal Verification
A distillation or purity-testing claim is recorded, but no contaminant test results are supplied.
Ingredient Source Transparency
A small-fish or krill source is recorded for the oil; its identity and sustainability are not independently verified.

Value80

The whole-product cost works out to about $0.93 per gram of DHA.
Price per Gram of DHA
The whole-product cost works out to about $0.93 per gram of DHA.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE · Journal of the American Heart Association · 2020
    Meta-analysis127,477 participants13 studies pooledCardiovascular Support forFish Oil
  2. Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
    Lu J; Liu R; Ren H; Wang S; Hu C; Shi Z; Li M; Liu W; Wan Q; Su Q; Li Q; Zheng H; Qu S; Yang F; Ji H; Lin H; Qi H; Wu X; Wu K; Chen Y; Xu Y; Xu M; Wang T; Zheng J; Ning G; Zheng R; Bi Y; Zhong H; Wang W · Med (New York, N.Y.) · 2025
    Randomized trial309 participantsCardiovascular Support forFish Oil
  3. A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
    Campbell F; Dickinson HO; Critchley JA; Ford GA; Bradburn M · European journal of preventive cardiology · 2013
    Meta-analysis1,524 participants17 studies pooledCardiovascular Support forFish Oil
  4. Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
    Zeng Q; Dong SY; Liu YP; Fu J; Shuai P; Zhao ZM; Li TX · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2017
    Randomized trial422 participantsCardiovascular Support forFish Oil
  5. Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Sekikawa A; Cui C; Sugiyama D; Fabio A; Harris WS; Zhang X · Nutrients · 2020
    Meta-analysis6 studies pooledCardiovascular Support forFish Oil
  6. Supplementation with vitamin E alone is associated with reduced myocardial infarction: a meta-analysis.
    Loffredo L; Perri L; Di Castelnuovo A; Iacoviello L; De Gaetano G; Violi F · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2016
    Meta-analysis16 studies pooledCardiovascular Support forVitamin E
  7. Vitamin E ameliorates blood cholesterol level and alters gut microbiota composition: A randomized controlled trial.
    Chen B; Li Y; Li Z; Hu X; Zhen H; Chen H; Nie C; Hou Y; Zhu S; Xiao L; Li T · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2025
    Randomized trial90 participantsCardiovascular Support forVitamin E
  8. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
    Lonn E; Bosch J; Yusuf S; Sheridan P; Pogue J; Arnold JM; Ross C; Arnold A; Sleight P; Probstfield J; Dagenais GR; HOPE and HOPE-TOO Trial Investigators · JAMA · 2005
    Randomized trial9,541 participantsCardiovascular Support forVitamin E
  9. Independent and combined associations of dietary antioxidant exposure with all-cause and cause-specific mortality in the general population.
    Liu Z; He Z; Xing Y · Journal of nutritional science · 2026
    Cohort study34,955 participantsCardiovascular Support forVitamin E
  10. Tocotrienol rich fraction supplementation improved lipid profile and oxidative status in healthy older adults: A randomized controlled study.
    Chin SF; Ibahim J; Makpol S; Abdul Hamid NA; Abdul Latiff A; Zakaria Z; Mazlan M; Mohd Yusof YA; Abdul Karim A; Wan Ngah WZ · Nutrition & metabolism · 2011
    Randomized trial62 participantsCardiovascular Support forVitamin E
  11. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
    Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Saito Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Japan EPA lipid intervention study (JELIS) Investigators · Lancet (London, England) · 2007
    Randomized trial18,645 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  12. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
    Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; JELIS Investigators, Japan · Atherosclerosis · 2008
    Randomized trial14,981 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  13. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G · European journal of preventive cardiology · 2024
    Meta-analysis134,144 participants18 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  14. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
    Matsuzaki M; Yokoyama M; Saito Y; Origasa H; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Matsuzawa Y; JELIS Investigators · Circulation journal : official journal of the Japanese Circulation Society · 2009
    Randomized trialHeart Health forEPA (Eicosapentaenoic Acid)
  15. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology · Circulation · 2020
    OtherHeart Health forEPA (Eicosapentaenoic Acid)
  16. Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
    Song J; Hu M; Li C; Yang B; Ding Q; Wang C; Mao L · Food & function · 2018
    Randomized trial201 participantsInflammation forFish Oil
  17. Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
    Lin YL; Wang CL; Chiang TI · Frontiers in nephrology · 2024
    Randomized trial60 participantsInflammation forFish Oil
  18. Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
    Yang B; Ren XL; Li ZH; Shi MQ; Ding F; Su KP; Guo XJ; Li D · Food & function · 2020
    Randomized trial77 participantsInflammation forFish Oil
  19. The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
    Meng Z; Dong Y; Gao H; Yao D; Gong Y; Meng Q; Zheng T; Cui X; Su X; Tian Y · The Journal of international medical research · 2019
    Randomized trial174 participantsInflammation forFish Oil
  20. Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Liu R; Jiang J; Fu Z; Liu C; Yao L; Quan H · Journal of the American Nutrition Association · 2022
    Meta-analysis49 studies pooledInflammation forFish Oil